Home > M&A deals 2017 > Aisling Capital and Vivo Capital acquire a stake in Harmony Biosciences LLC
Stake Purchase · Life Science · October 2017

Aisling Capital and Vivo Capital acquire a stake in Harmony Biosciences LLC

On October 6, 2017, Aisling Capital and Vivo Capital acquired a stake in Harmony Biosciences LLC, a life science company in Pennsylvania, United States.

Deal at a glance

AnnouncedOctober 6, 2017 TypeStake Purchase TargetHarmony Biosciences LLC Buyers Aisling Capital
Vivo Capital SectorLife Science LocationPennsylvania, United States ValueNot disclosed

Target company

Harmony Biosciences LLC
Pennsylvania, United States
Life Sciencesector
-founded
Activestatus
View the company profile →

Buyers (2)

Aisling Capital Lead
Private equity firm · 88 deals on record
Vivo Capital Co-investor
Company · 20 deals on record
  • 27th transaction for the lead buyer in life science
  • 36th transaction in United States
88deals, all time
65in this sector
2020latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Orbus Therapeutics, Inc.Same sector and country · Oct 2026
ArtesRx LLCSame sector and country · Aug 2026
Firefly Bio, Inc.Same sector and country · Jul 2026

Questions about this deal

Who acquired Harmony Biosciences LLC?Aisling Capital and Vivo Capital acquired a stake in Harmony Biosciences LLC on October 6, 2017.

What type of deal was it?It was a stake purchase in the life science sector in 2017.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).